MiMedx Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
MiMedx Group, Inc. (MDXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 1.68% for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2017-03-01
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2015-03-31 was 1.66%, a 15.31% decline year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2014-03-31 was 1.96%, a 5.38% increase year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2013-03-31 was 1.86%, a 111.36% increase year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2012-03-31 was 0.88%.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 1.68%, a 14.29% decline from fiscal 2014.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2014 was 1.96%, a 4.26% increase from fiscal 2013.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2013 was 1.88%, a 6.21% increase from fiscal 2012.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2012 was 1.77%, a 20.98% decline from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month as first filed |
|---|---|---|---|---|---|---|
| 2015-12-31 | 1.68% 10-K · filed 2017-03-01 | |||||
| 2015-09-30 | 1.68% 10-Q · filed 2016-11-08 | |||||
| 2015-06-30 | 1.68% 10-Q · filed 2016-08-02 | |||||
| 2015-03-31 | 1.66% 10-Q · filed 2016-05-10 | |||||
| 2014-12-31 | 1.96% 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | 1.96% 10-Q · filed 2015-11-06 | |||||
| 2014-06-30 | 1.96% 10-Q · filed 2015-08-07 | |||||
| 2014-03-31 | 1.96% 10-Q · filed 2015-05-01 | |||||
| 2013-12-31 | 1.88% 10-K · filed 2017-02-22 | |||||
| 2013-09-30 | 1.88% 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | 1.13% 10-Q · filed 2014-08-11 | 0.85% 10-Q · filed 2013-08-08 | ||||
| 2013-03-31 | 1.86% 10-Q · filed 2014-05-12 | |||||
| 2012-12-31 | 1.77% 10-K · filed 2015-03-13 | 0.18% 10-K · filed 2013-03-15 | ||||
| 2012-09-30 | 1.62% 10-Q · filed 2013-11-08 | |||||
| 2012-06-30 | 1.48% 10-Q · filed 2013-08-08 | 0.12% 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | 0.88% 10-Q · filed 2013-05-10 | |||||
| 2011-12-31 | 2.24% 10-K · filed 2014-03-04 | |||||
| 2011-09-30 | 2.24% 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | 2.24% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |